NCT01272037
Clinical Trial Information
Trial Number: NCT01272037 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A PHASE III, RANDOMIZED CLINICAL TRIAL OF STANDARD ADJUVANT ENDOCRINE THERAPY+/- CHEMOTHERAPY IN PATIENTS WITH 1-3 POSITIVE NODES, HORMONE RECEPTOR-POSITIVE AND HER2-NEGATIVE BREAST CANCERWITH RECURRENCE SCORE (RS) OF 25 OR LESS. RXPONDER: A CLINICAL TRIAL RX FORPOSITIVE NODE, ENDOCRINE RESPONSIVE BREAST CANCER
Study ID:
S1007
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01272037-D2 | There are two dataset submissions associated with this publication: NCT01272037-D1 and NCT01272037-D2. This dataset, NCT01272037-D2, contains toxicity data at the event level (one row per adverse event per participant) reported in PMID 34914339. |
| NCT01272037-D1 | There are two dataset submissions associated with this publication: NCT01272037-D1 and NCT01272037-D2. This dataset, NCT01272037-D1, contains participant-level data on invasive disease-free survival, distant relapse-free survival, and participant characteristics in PMID 34914339. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®